They sue me because the medicine is illegal, but if it is legal, they say I can't afford it?

Chapter 302: Preparing to Use Any Means.



Chapter 302: Preparing to Use Any Means.

……

“We’ve been shorted?”

"Two hundred billion US dollars? Who did this?"

When Mursi learned the news, he was extremely shocked.

Pfizer has had enough troubles recently, and now a huge short-selling has suddenly emerged.

You know, Pfizer's market value has fallen by half, from $4000 billion to $2000 billion.

As the chairman and chief operating officer, Mursi was naturally not in a very good mood.

Today, Pfizer is being shorted again, and it is a huge shorting, with a position of up to 20 billion US dollars.

This made Mursi even more anxious and it was impossible for him not to be nervous.

Because he knows that these short selling will not bring any benefits.

If they were not sure, these short sellers would not have shorted a company on such a large scale, let alone a giant like Pfizer.

Because of this, he realized that these short sellers must have discovered some problem, which is why they were short selling so crazily.

“What’s wrong with us at Pfizer?”

"No matter what, we must first conduct self-examination this time and cannot let these short sellers be exposed first."

"But could this be related to Antai Pharmaceutical Group? The market believes that Antai Pharmaceutical Group's new drugs will have a significant impact on Pfizer, which is why they are shorting Pfizer?"

At the meeting, Murthy brought this up.

Many executives looked at each other in confusion. Even if they were asked to conduct a self-inspection now, they would not be able to find everyone.

Even if they really find any problems, they dare not say it directly, so as not to suffer the consequences first.

After all, for an old giant like Pfizer, the internal network of power relations is complicated and the interests are tangled and confusing, and no one knows what big problems will arise.

"Antai Pharmaceutical Group's new drug does overlap with our Pfizer's."

"But the problem is that these overlapping drugs only account for a very small proportion of our Pfizer portfolio."

"Even if this drug is abandoned, there won't be much impact, so why is the market reacting so strongly?"

A young blond-haired, blue-eyed female executive raised her question.

She didn't understand why a drug that didn't contribute much to revenue would have such a big impact.

Even if Pfizer abandons this drug, it will not suffer any serious consequences. Why does the market react so badly?

Mursi glanced at the other person with a somewhat puzzled expression.

He knew that the other party was ignorant, but he didn't know that he was ignorant to this extent.

It would be fine if he was ignorant, but if he didn't have the ability he should just be low-key, but he had to show it off.

But there was nothing he could do. The other party was arranged by the board of directors, and he couldn't do anything to him.

“The market doesn’t look at our current revenue, but at our future revenue.”

"These drugs don't generate much revenue right now, but Pfizer is undergoing a transformation, and we need to demonstrate to the market our commitment and confidence in this transformation."

"These drugs are part of our strategy, and we just announced this strategy when Antai Pharmaceutical Group targeted the market. This will naturally reduce our confidence in our transformation, which will also be reflected in the stock price."

At this time, an executive began to explain.

He tried his best to make the other party understand the market reaction and stop asking such basic questions.

If the other party continues to ask such questions, it will definitely affect the meeting and in the end nothing can be said.

Hearing this, the young woman nodded. It was unclear whether she really understood or was just pretending to understand, but the latter was more likely.

"Let's investigate what's going on first."

"Why these short sellers shorted Pfizer must be thoroughly investigated."

"Also, investigate the short-selling issue and see if it has anything to do with Antai Pharmaceutical Group. Could it be that the short-selling originated from China?"

Mursi made arrangements immediately.

The most urgent task now is to first understand the reasons for short selling.

Being shorted for no reason and if the reason cannot be found out, that would be the worst thing.

First, you need to know the reasons for being shorted, so that you can come up with ways to deal with it and minimize the cost of shorting.

"In addition, we must accelerate our cooperation with Antai Pharmaceutical Group."

"If Antai Pharmaceutical Group's new drug patents can be transferred to our group, Pfizer's transformation will not be a problem."

Mursi brought up the plan again.

Pfizer's biggest problem right now is that it doesn't have any blockbuster drugs.

If no new revenue sources are created, future revenue and profits will plummet, and the market will become even more embarrassing.

But as long as Pfizer can find new profit points and have new drugs to fill these gaps, all the problems will no longer be problems.

Coincidentally, several drug patents of Antai Pharmaceutical Group fit this situation very well.

If these drug patents fall into Pfizer's hands, Pfizer's revenue will reach $1000 billion again, and there is hope that it will even reach a new high.

Therefore, the chairman, Mulixi, is still thinking about acquiring the new drug formula.

"Our people have made contact."

"But Chen Xuan has no sincerity in cooperating. He doesn't want to transfer the patent for the new drug at all."

"Also, we received news that Huaxia provided Antai Pharmaceutical Group with a 400 billion interest-free loan. Now that they are not short of money, it is even less likely that they will cooperate with us."

An executive on the left spoke in a deep voice.

Pfizer’s senior executives are not all just people with connections who just sit there and do nothing. There are also many people who are capable of doing things.

They have been investigating the matter and analyzing the possibility of cooperation between the two sides, and will report to Mursi at any time.

The current situation is certainly not optimistic.

Pfizer desperately needs Aetna Pharmaceuticals' new drug patents, but it is obvious that Chen Xuan is not likely to cooperate.

Especially with Huaxia's support behind the scenes, no matter how much money Antai Pharmaceutical Group needs, it is not a problem, so cooperation is even less likely.

Hearing this,

Mursi couldn't help but fall into silence.

"You find a way to get Chen Xuan to go abroad."

"As long as he goes abroad, preferably to America, things will be much easier. He will definitely be willing to talk then."

"For example, we could invite him to go abroad in the name of academic exchange, or we could mobilize the Nobel Committee to send some signals that he will win the prize, so that he is willing to go abroad."

"In short, no matter what reason you use, he must leave China."

Looking forward with gloomy eyes, Mursi spoke in a deep voice.

He wanted Chen Xuan to come to America for talks. It didn't matter how they were discussed, but he had to let Chen Xuan come first.

Any conditions can be negotiated, but once the latter arrives in America, they will have no say in the matter and it will be impossible for them to refuse.

That's why he came up with so many reasons to invite Chen Xuan to go abroad.

Academic exchange is one way.

The Nobel Prize is another way.

Of course, Pfizer has no way to directly interfere with the Nobel Committee, but it can influence some members of the committee.

Now we are just asking these members to send a signal to the outside world, not asking them to directly present the award to Chen Xuan, so of course there will be no problem.

In Mursi's view, as long as these committee members send out this signal,

If Chen Xuan thought he could win the Nobel Prize, he would definitely be willing to go abroad for exchanges.

Then, Mulshi can take action.

Just force them to cooperate with you, otherwise they will never be able to go back.

As for whether I can go back after the cooperation?

That depends on his mood.

Wouldn't that be a bit mean?

Mursi would never think so.

The market should be unscrupulous.

What's more, the benefits are hundreds of billions of dollars, so there is no need to worry about the means used.

In short, we must try every possible way to get Chen Xuan to go abroad, any method will do.

"Yes, we will arrange it."

"Then we can get the media to cooperate and create the signal that Chen Xuan is going to win the award. He should believe it."

All the executives responded in unison.

Although Mursi didn't say it explicitly, they all knew what he meant.

There were ulterior motives in letting Chen Xuan go abroad, especially letting him come to the United States for academic exchanges, which was even more obvious.

But they didn't think there was a problem, and no one raised any objection.

Anyway, this is not the first time they have done such a thing.

……


Tip: You can use left, right, A and D keyboard keys to browse between chapters.